Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,913 | -13,714 | -139,805 | -90,616 | -80,299 |
| Depreciation Amortization | 6,648 | 3,193 | 16,490 | 13,292 | 8,982 |
| Income taxes - deferred | 13 | 13 | -5,238 | -4,937 | -4,338 |
| Accounts receivable | 7,091 | 3,612 | -10,753 | -9,438 | -8,128 |
| Accounts payable and accrued liabilities | -4,681 | 157 | 414 | -3,615 | -3,402 |
| Other Working Capital | -1,871 | -551 | -14,905 | -19,360 | -19,042 |
| Other Operating Activity | 6,283 | 4,578 | 145,309 | 98,329 | 88,386 |
| Operating Cash Flow | $-10,430 | $-2,712 | $-8,488 | $-16,345 | $-17,841 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,904 | -3,295 | -10,385 | -5,937 | -3,491 |
| Purchase Of Investment | -15,728 | -8,202 | -53,116 | -35,767 | -23,075 |
| Sale Of Investment | 34,402 | 15,424 | 8,920 | 750 | N/A |
| Other Investing Activity | -2,552 | -1,001 | -3,536 | -2,269 | -774 |
| Investing Cash Flow | $12,218 | $2,926 | $-58,117 | $-43,223 | $-27,340 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 20,000 | 20,000 | N/A |
| Debt Repayment | -256 | -127 | -2,164 | -2,120 | -247 |
| Common Stock Issued | 306 | 125 | 323 | 307 | 301 |
| Other Financing Activity | 92 | -560 | -1,843 | -1,246 | -524 |
| Financing Cash Flow | $142 | $-562 | $16,316 | $16,941 | $-470 |
| Exchange Rate Effect | 28 | 11 | -108 | -176 | -190 |
| Beginning Cash Position | 19,473 | 19,473 | 69,870 | 69,870 | 69,870 |
| End Cash Position | 21,431 | 19,136 | 19,473 | 27,067 | 24,029 |
| Net Cash Flow | $1,958 | $-337 | $-50,397 | $-42,803 | $-45,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,430 | -2,712 | -8,488 | -16,345 | -17,841 |
| Capital Expenditure | -3,904 | -3,295 | -10,385 | -5,937 | -3,491 |
| Free Cash Flow | -14,334 | -6,007 | -18,873 | -22,282 | -21,332 |